Best Orserdu (Elacestrant Di Hcl) Medicine in India

Orserdu (Elacestrant Di Hcl) is a hormonal anticancer medicine used to treat certain adults with estrogen receptor-positive (ER-positive), HER2-negative advanced or metastatic breast cancer with an ESR1 mutation, particularly when the disease has progressed after at least one line of endocrine therapy. It belongs to a group of medicines called estrogen receptor antagonists and works by binding to and degrading estrogen receptors, reducing estrogen-driven signals that cancer cells need to grow.

Orserdu (Elacestrant Di Hcl) should be taken exactly as prescribed by your doctor, usually once daily with food, at approximately the same time each day. Swallow the medicine whole with water and do not crush, chew, or split it. Treatment is generally continued as long as recommended by your healthcare professional based on your response and tolerance. Regular medical check-ups and blood tests may be required to monitor your health and treatment response.

Common side effects of Orserdu may include muscle or joint pain, nausea, increased cholesterol, fatigue, vomiting, decreased appetite, diarrhea, headache, constipation, and hot flashes. It may also cause serious liver problems or other significant adverse effects in some patients. Inform your doctor promptly if you develop severe or persistent symptoms, yellowing of the skin or eyes, dark urine, or unusual abdominal pain. Before starting treatment, tell your doctor about any medical conditions and all medicines, vitamins, herbal products, and dietary supplements you are taking.

Treatment of ER-Positive, HER2-Negative Breast Cancer

Orserdu (Elacestrant Di Hcl) is used to treat certain adults with estrogen receptor-positive (ER-positive), HER2-negative advanced or metastatic breast cancer with an ESR1 mutation, particularly when the cancer has progressed after previous endocrine therapy. It works by binding to and degrading estrogen receptors in cancer cells, reducing estrogen-driven signals that support cancer growth. This helps slow cancer cell growth and may delay disease progression in eligible patients.

Some side effects of Orserdu (Elacestrant Di Hcl) may improve as the body adjusts to the medicine. Consult your doctor if any side effect persists, becomes severe, or causes concern.

Common Side Effects of Orserdu (Elacestrant Di Hcl)

Orserdu (Elacestrant Di Hcl) should be taken exactly as prescribed by your doctor, usually once daily with food, at approximately the same time each day. Swallow the medicine whole with water and do not crush, chew, or split it. Continue treatment for as long as recommended by your healthcare professional. Regular medical check-ups and tests may be required to monitor your response to treatment and overall health.

Orserdu (Elacestrant Di Hcl) is an oral estrogen receptor antagonist and degrader (SERD). It binds to estrogen receptors in cancer cells and promotes their breakdown, reducing estrogen-dependent signals that can support cancer cell growth. This helps slow the growth and progression of ESR1-mutated, ER-positive, HER2-negative advanced or metastatic breast cancer.

• Maintain the medicine at a controlled room temperature of 20°C to 25°C (68°F to 77°F).
• Keep the product in a dry area, protected from excessive heat and direct light.
• Leave it in the original packaging until it is ready to be used.
• Store the medicine securely in a place inaccessible to children.

Alcohol CONSULT YOUR DOCTOR

Consult your doctor before consuming alcohol during treatment with Orserdu (Elacestrant Di Hcl), especially if you have liver problems.

Pregnancy CONSULT YOUR DOCTOR

Orserdu may harm an unborn baby. Inform your doctor if you are pregnant or planning to become pregnant. Use effective contraception as advised by your doctor.

Breastfeeding CONSULT YOUR DOCTOR

Do not breastfeed during treatment with Orserdu and for the recommended period after the final dose. Consult your doctor for guidance.

Driving CONSULT YOUR DOCTOR

Orserdu may cause fatigue, dizziness, or other effects that can affect your ability to drive safely. Avoid driving if these symptoms occur.

Kidney CAUTION

Inform your doctor if you have kidney problems before starting treatment. Your doctor may recommend appropriate monitoring.

Liver CAUTION

Tell your doctor if you have liver problems. Elacestrant may affect liver function, so your doctor may recommend regular liver-function monitoring.

• Take Orserdu (Elacestrant Di Hcl) exactly as prescribed by your doctor and follow the recommended daily treatment schedule.
• Take the medicine with food at approximately the same time each day and swallow it whole with water.
• Attend regular medical check-ups and tests to monitor cholesterol levels, liver function, and your response to treatment.
• Contact your doctor if you experience persistent nausea, vomiting, severe fatigue, abdominal pain, or other concerning symptoms.
• Inform your doctor about all medicines, vitamins, herbal products, and dietary supplements you are taking to help prevent possible drug interactions.
• Read More About - Orserdu (Elacestrant Di Hcl) from Pharma Five.

Pharma Five, can assist patients with the import of Orserdu (Elacestrant Di Hcl) in small quantities for personal medical use. For this purpose, the applicant must submit an application in Form 12A along with a prescription issued by a Registered Medical Practitioner (RMP).

With more than two decades of pharmaceutical experience, Pharma Five provides professional support to patients seeking access to Orserdu (Elacestrant Di Hcl) and other specialized medicines through import facilitation. Pharma Five provides extensive pharmaceutical service coverage across India, serving patients and healthcare requirements in prominent cities such as Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.